A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04481685 · COMPLETED
Trial details
- NCT number
- NCT04481685
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-02-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.